NR 565 Week 1 Midterm - Study
Guide for Mid Term
Advanced Pharmacology
Fundamentals (Chamberlain
University)
,NR565: Advanced Pharmacology - Week 1
Chapter 1: Prescriptive Authority
- Prescriptive Authority: legal right to prescribe drugs
• Full Practice Authority: legal right to prescribe independently &
without limitation (i.e. physicians)
• Non-physician providers usually have restricted - tied to
oversight by an MD or DO
• 2 components:
- The right to prescribe independently (not subject to rules
requiring physician supervision or collaboration)
- The right to prescribe without limitation (prescribe any drugs,
including controlled drugs, with the exception of schedule I
drugs, which have no current medical use)
• PAs required to have an affiliation with a physician in order to
practice & prescribe
• APRNs full prescriptive authority depends on their legal right to
prescribe without a supervisory or collaborative requirement
- Educated to practice & prescribe independently without supervision
- Certain states require collaboration with or under a physician
(some physicians can limit the types of drugs the APRN can
prescribe)
- State laws may place additional restrictions with regard to
controlled drugs
- Collaborative States: Alabama, Arkansas, California,
Connecticut, Delaware, Florida, Georgia, Illinois, Indiana,
Kansas, Kentucky, Louisiana, Massachusetts (CNP, CNS,
CRNA), Michigan, Mississippi, Missouri, Nebraska, New
Jersey, North Carolina, Ohio, Oklahoma, Pennsylvania, South
Carolina, Tennessee, Texas, Vermont, Virginia, West Virginia,
Wisconsin
,1
, - Independent States: Alaska, Arizona, Colorado, Hawaii, Idaho,
Iowa, Maine, Maryland, Massachusetts (CNM), Minnesota,
Montana, Nevada, New Hampshire, New Mexico, New York,
North Dakota, Oregon, Rhode Island, South Dakota, Utah,
Washington, Wyoming
• Regulations
- Determined by state law
- Locum tenens: practicing in two states
- Under the jurisdiction of a health professional board (i.e. State
Board of Nursing, State Board of Medicine, or State Board of
Pharmacy, as determined by each state)
- Federal government has no control over prescriptive authority
Chapter 3: Promoting Positive Outcomes of Drug Therapy
- Medication Education Components:
• Medication Name
- Avoid patient referring to medication by the usage & not the
name (i.e. “blood pressure pill” - increases risk for medication
errors)
- Encourage patients to keep a list of their medications on their
person at all times (include both generic & brand name)
• Knowing the generic name empowers the patient to catch
medication errors in the event that two different providers
prescribe the same generic drug under different brand names
• Purpose
• Dosing Regimen
- Drug quantity & number of tablets or millimeters per dose
needs to be reviewed with the patient (will also be on the
prescription label)
- Be specific with timing (i.e. “four times a day” vs “once a day”)
Guide for Mid Term
Advanced Pharmacology
Fundamentals (Chamberlain
University)
,NR565: Advanced Pharmacology - Week 1
Chapter 1: Prescriptive Authority
- Prescriptive Authority: legal right to prescribe drugs
• Full Practice Authority: legal right to prescribe independently &
without limitation (i.e. physicians)
• Non-physician providers usually have restricted - tied to
oversight by an MD or DO
• 2 components:
- The right to prescribe independently (not subject to rules
requiring physician supervision or collaboration)
- The right to prescribe without limitation (prescribe any drugs,
including controlled drugs, with the exception of schedule I
drugs, which have no current medical use)
• PAs required to have an affiliation with a physician in order to
practice & prescribe
• APRNs full prescriptive authority depends on their legal right to
prescribe without a supervisory or collaborative requirement
- Educated to practice & prescribe independently without supervision
- Certain states require collaboration with or under a physician
(some physicians can limit the types of drugs the APRN can
prescribe)
- State laws may place additional restrictions with regard to
controlled drugs
- Collaborative States: Alabama, Arkansas, California,
Connecticut, Delaware, Florida, Georgia, Illinois, Indiana,
Kansas, Kentucky, Louisiana, Massachusetts (CNP, CNS,
CRNA), Michigan, Mississippi, Missouri, Nebraska, New
Jersey, North Carolina, Ohio, Oklahoma, Pennsylvania, South
Carolina, Tennessee, Texas, Vermont, Virginia, West Virginia,
Wisconsin
,1
, - Independent States: Alaska, Arizona, Colorado, Hawaii, Idaho,
Iowa, Maine, Maryland, Massachusetts (CNM), Minnesota,
Montana, Nevada, New Hampshire, New Mexico, New York,
North Dakota, Oregon, Rhode Island, South Dakota, Utah,
Washington, Wyoming
• Regulations
- Determined by state law
- Locum tenens: practicing in two states
- Under the jurisdiction of a health professional board (i.e. State
Board of Nursing, State Board of Medicine, or State Board of
Pharmacy, as determined by each state)
- Federal government has no control over prescriptive authority
Chapter 3: Promoting Positive Outcomes of Drug Therapy
- Medication Education Components:
• Medication Name
- Avoid patient referring to medication by the usage & not the
name (i.e. “blood pressure pill” - increases risk for medication
errors)
- Encourage patients to keep a list of their medications on their
person at all times (include both generic & brand name)
• Knowing the generic name empowers the patient to catch
medication errors in the event that two different providers
prescribe the same generic drug under different brand names
• Purpose
• Dosing Regimen
- Drug quantity & number of tablets or millimeters per dose
needs to be reviewed with the patient (will also be on the
prescription label)
- Be specific with timing (i.e. “four times a day” vs “once a day”)
